Tinker Anna V, Boussioutas Alex, Bowtell David D L
Ian Potter Centre for Cancer Genomics and Predictive Medicine, Peter MacCallum Cancer Centre, St. Andrew's Place, East Melbourne 3002, Victoria, Australia.
Cancer Cell. 2006 May;9(5):333-9. doi: 10.1016/j.ccr.2006.05.001.
Large-scale genomic studies promise to advance our understanding of the biology of human cancers and to improve their diagnosis, prognostication, and treatment. The analysis and interpretation of genomics studies have faced challenges. The retrospective and observational design of many studies has rendered them susceptible to confounding and bias. Technological variations and advances have impacted on reproducibility. Statistical hurdles in relating a large number of variables to a small number of observations have added further constraints. This review considers the promise and challenge associated with the large-scale clinically oriented genomic analysis of human cancer and attempts to emphasize potential solutions.
大规模基因组研究有望增进我们对人类癌症生物学的理解,并改善其诊断、预后评估和治疗。基因组学研究的分析和解读面临诸多挑战。许多研究的回顾性和观察性设计使其容易受到混杂因素和偏差的影响。技术差异和进步对可重复性产生了影响。将大量变量与少量观察结果相关联时存在的统计障碍进一步增加了限制。本综述探讨了与人类癌症大规模临床导向基因组分析相关的前景与挑战,并试图强调潜在的解决方案。